Efficacy Study of Metformin Glycinate on Postprandial Lipemia

Inclusion Criteria: * Patients of both sexes * Between 35 and 65 years old * Patients with type 2 diabetes within two years of diagnosis according to the ADA criteria * Overweight patients (BMI between 25.5 and 29.9 kg/m2) or with grade 1 obesity (BMI between 30.0 and 34.9 kg/m2), according to WHO classification * Low HDL levels: \<50 in women and \<40 mg/dL in men * Hypertriglyceridemia: \>150 and less than 300 mg/dL * Patients who had not taken antidiabetes drug treatment or with diet and exercise treatment, or with metformin or DPP4 inhibitor monotherapy * HbA1c between 6.5 and 8.5%. * Creatinine clearance \>60 ml/min (calculated by Cockcroft and Gault) * Informed consent form signed. * Women using contraception. Exclusion Criteria: * Patients with other types of diabetes (type 1, LADA, MODY, etc.). * Patients with primary dyslipidemia. * Patients with poorly substituted hypothyroidism TSH \> 5 mU/mL. * Patients hospitalized in the last month. * Patients with a disease of poor short-term prognosis * Patients with autoimmune or rheumatic diseases. * Patients with acute infection or febrile illness. * History of chronic liver disease or ALT or AST ≥ 2.0 times the upper limit of normal, or GGT ≥ 3 times the upper limit of normal. * Patients with any other chronic disease, for example: HIV, rheumatic diseases. * Pregnant or positive pregnancy test. * Women who are breastfeeding. * Patients in another research project.